Current Status of Clinical Trials of Therapeutic Modalities for Malignant Melanoma in Australiadoi:10.1111/j.1600-0749.1989.tb00223.xALANSydneyCOATESSydneyWileyPigment Cell ResearchCoates. A, Current Status of Clinical Trials of Therapeutic Modalities for Malignant Melanoma in Australia. Pigment Cell ...
To determine current practice in the delivery of parenteral nutrition (PN) in Australian hospitals. A cross-sectional mail survey. Acute-care adult hospitals with greater than 200 beds in Australia. A total of 67 hospitals (65.7% response rate). Surveys
Current preventive strategies and clinical services in this domain of adolescent health in Australia are deficient. Australia can learn from the innovative and effective strategies developed in various countries for preventing high-risk sexual behaviours in teenagers....
doi:10.5694/mja2.50673Joshua S DavisDavid FerreiraJustin T DenholmSteven YC TongThe Medical journal of Australia
These market share losses among developed bio-pharmaceutical markets were partially offset by the rapid growth of BPCT sites in Japan (1.2%), and Australia and New Zealand (0.3%). During the same period, emerging markets gained 2.1% global market share. Among emerging markets, CEE continues to...
Templeton DJ, Jin F, Prestage GP, Donovan B, Imrie JC, Kippax SC, Cunningham PH, Kaldor JM, Mindel A, Cunningham AL, Grulich AE. Circumcision and risk of sexually transmissible infections in a community-based cohort of HIV-negative homosexual men in Sydney, Australia. J Infect Dis. 2009;...
In this context, focus has shifted to biologic and immunomodulatory agents, of which the histone deacetylase inhibitor (HDACi) romidepsin has attracted interest for its tolerability and proven efficacy in around one-third of patients in two pivotal clinical trials.Areas covered: In this review, we...
Ai-Guo,Ren - 《World Journal of Clinical Pediatrics》 被引量: 33发表: 2015年 Folate and the prevention of neural tube defects: evaluation of a health promotion project in Western Australia The objectives of this study were: to inform health professionals and women of childbearing age about the...
development. Many of these therapies are currently undergoing clinical trials. This review summarises the latest emerging therapies that may become mainstream treatment in the coming years. It is distinct from other recent reviews in the field by comprehensively addressing both pharmacological non-...
Adverse prognostic impact of even mild or moderate tricuspid regurgitation: insights from the National Echocardiography Database of Australia. J Am Soc Echocardiogr. 2022;35:810–7. Article PubMed Google Scholar Taramasso M, Benfari G, van der Bijl P, Alessandrini H, Attinger-Toller A, ...